News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
Starting treatment
Starting ART at a high CD4 cell count has clear benefits for people with a low viral load

Starting antiretroviral therapy (ART) has significant benefits and entails few risks for individuals with a low pre-treatment viral load, according to analysis of results from a large treatment

Published
10 July 2019
By
Michael Carter
Starting treatment
Immediate treatment is probably especially beneficial for people with recent HIV infection

Immediate initiation of antiretroviral treatment produced the biggest boost in CD4 cell count for people infected with HIV less than six months previously, an analysis of the

Published
03 July 2019
By
Keith Alcorn
New and experimental HIV treatments
1 Year After Approval: How Does D/C/F/TAF Measure Up?

The US Food and Drug Administration (FDA) approved the first darunavir-based single-tablet regimen (STR) for the treatment of HIV in July 2018. Now, nearly a year since its launch, health care practitioners and patients alike are evaluating its place in the HIV treatment landscape.

Published
01 July 2019
From
Contagion Live
Resistance
Genotype Testing at HIV Diagnosis Provides No Benefit

For the majority of people with HIV in the US, the current treatment guidelines recommend an integrase strand inhibitor paired with an NRTI as first-line ART. Therefore, baseline genotype results currently guide the choice of initial NRTI pair, given transmitted NRTI resistance (NRTI-R). With this evolution of HIV treatment, the role and value of baseline genotype testing has become uncertain. This study determined the clinical and economic value of baseline genotype testing for people newly diagnosed with HIV in the US.

Published
25 June 2019
From
Infectious Disease Advisor
Combatting stigma
What works against self-stigma? First systematic review aims to find out

A systematic review of whether different interventions helped to overcome self-stigma in people in African and Asian countries who are living with or at risk of HIV

Published
24 May 2019
By
Gus Cairns
How HIV works
Early antiretroviral treatment may preserve key immune responses to HIV

Investigators from the Ragon Institute of MGH, MIT and Harvard have found that instituting combination antiretroviral treatment at the earliest stages of HIV infection may allow the generation of functional CD8 'killer' T cells and preservation of the CD4 helper T cells that are the virus's primary target.

Published
23 May 2019
From
Eurekalert Inf Dis
Starting treatment
Immediate HIV treatment initiation has improved but not yet universal in NYC, study finds

A new study published in the Journal of Infectious Diseases found that immediate treatment initiation for HIV infection has improved since local and federal guidelines began to recommend universal treatment for all persons diagnosed with HIV, regardless of their disease stage.

Published
07 May 2019
From
News-Medical.net
Undetectable viral load and treatment as prevention
Most UK clinic staff now tell people about U=U, but not always in the same way

Two presentations at this month’s British HIV Association (BHIVA) conference in Bournemouth show that most specialist healthcare workers are now informing people with HIV that if their

Published
29 April 2019
By
Gus Cairns
Starting treatment
US regulators approve new two-drug combination pill for HIV

The US Food and Drug Administration (FDA) this week approved Dovato, a new single-tablet antiretroviral regimen containing the HIV integrase inhibitor dolutegravir (sold separately as Tivicay) and

Published
11 April 2019
By
Liz Highleyman
Health monitoring in resource-limited settings
Are CD4 counts still useful in the 'treat all' era?

CD4 cell testing before starting treatment is still essential even in the era of 'treat all' guidelines, two studies from southern Africa presented at the Conference on

Published
08 March 2019
By
Keith Alcorn
← First12345...82Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.